RNA Formulation Solutions

  1. Contract Services To Optimize Continuous Nanoparticle Processing 10/16/2025

    DIANT Pharma provides continuous manufacturing systems and technical services for nanoparticle-based formulations. The company’s platform supports both research and manufacturing teams working on lipid nanoparticles (LNPs), liposomes, polymeric micelles, nucleic acid–lipid complexes, and other colloidal systems.

  2. Accelerate Development With Large-Scale mRNA And LNP Production 10/16/2024

    Achieve scalable purity with Vernal Biosciences' mRNA and lipid nanoparticle (LNP) large-scale production, tailored to meet the demands of your preclinical studies, including dose range finding and toxicology assessments.

  3. Systems For Lipid Nanoparticle (LNP) Production 12/6/2024

    Delve into the world of lipid nanoparticle (LNP) production and formulation, exploring cutting-edge technologies and applications in targeted drug delivery.

  4. Non-Viral In Vivo Transfection - Cationic Lipids For LNP Formulation 7/13/2023

    LipidBrick® IM21.7c

    •  Efficient: Modulates LNP properties to adapt the biodistribution depending on the therapeutic purpose
    •  Secure: Use a unique lipid structure protected by an independent patent owned by Polyplus®
    •  Accelerate your project: in vitro and in vivo proof of concept have been successfully performed
  5. in vivo mRNA Delivery Using Liposome-Based Reagent 12/12/2022

    in vivo-jetRNA®+ is a ready-to-use reagent that does not require formulation equipment that leads to 100% mRNA encapsulation leading to efficient mRNA delivery.

  6. Put Your Oligo Synthesis In Good Hands 1/27/2026

    Explore how smart column design supports consistent, high‑yield oligonucleotide synthesis, which formats fit development, and how optimized features help improve efficiency and safety.

  7. Pre-GMP mRNA And LNP Development 11/26/2024

    Leverage Pre-GMP mRNA and LNP development services to streamline process development, mitigate risks early, and accelerate your path to market with high-quality, compliant drug products.

  8. Complete Solutions For Every Step Of Pharmaceutical Development 1/12/2023

    By combining disruptive technology platforms with unparalleled genomic medicine development expertise, we're positioned to accelerate the development of LNP formulations and drug products.

  9. pDNA Lipid Nanoparticle Formulation And Screening Using Nova IJM 1/24/2024

    Explore a platform designed to evaluate the effects of formulation and process parameters on the characteristics of DNA+LNP nanoparticles.

  10. in vivo-jetRNA®+ 9/14/2022

    Efficient: 100% mRNA encapsulation leading to comparable LNP delivery results
    in vivo-jetRNA®+ is the reagent of choice to deliver mRNA to various organs. This is attributable to its intrinsic properties: in vivo-jetRNA®+ protects its payload against ubiquitous endonucleases, prevent non-specific interactions with proteins and promote efficient cell entry.